The three abstracts strengthen the clinical foundation for Iomab-ACT's development as a targeted conditioning platform for cellular and gene therapies across cancer and nonmalignant diseases Phase 1b/2 trial evaluates targeted immune conditioning with Iomab-ACT before standard commercial...
IASO Bio and its Singapore partner Pills and Pokes jointly hosted the FUCASO launch event in Singapore on November 3, marking the official commercial arrival of the world's first fully human BCMA-targeted CAR-T cell therapy in Singapore. FUCASO was approved by Singapore's Health Sciences...
Background: Stroke causes rapid neuronal death and gut barrier disruption in the acute phase, with persistent cognitive-affective impairment in the chronic phase. We previously showed that transplants of intestinal epithelial stem cells ameliorated the acute and chronic impairment of stroke. The…
Liver fibrosis is a major global cause of mortality that is driven by the activation of hepatic stellate cells (HSCs) into extracellular matrix (ECM)-producing myofibroblasts (MyoFs). The lack of predictive human in vitro models has severely hampered the discovery of targeted anti-fibrotic…
“We want to see a return to socializing in the schoolyards, conversations in the hallways and the focus and friendships that flourish in the classroom,” Mexico's education minister said. The post Cell phone ban takes effect in Mexico’s primary, secondary schools appeared first on Mexico News Daily
by The PLOS One Editors
Response to anti-PD-1 immunotherapy in advanced HPV-associated anal squamous cell carcinoma (ASCC) varies and is assessed by infrequent imaging that lags behind tumor biology. Circulating tumor DNA (ctDNA) can be sampled frequently and reflects near-real-time tumor activity yet is rarely built into…
Powered by Anthropic's Claude, Sentira Single Cell enables researchers to analyze Chromium data using natural language, accelerating the path from scientific questions to experimental conclusions PLEASANTON, Calif., Nov. 2, 2026 /PRNewswire/ -- 10x Genomics, Inc. (Nasdaq: TXG), the life...
The U.S. Food and Drug Administration today issued final guidance for manufacturers of cellular and gene therapy (CGT) products to implement a comprehensive, science- and risk-based plan for making sure their products meet potency standards.
